The risk score derived from combining the two most promising gene markers—HOXC6 and DLX1—with PSAD, DRE and PSA was found give the most accurate detection of high grade PCa on biopsy and was also successfully validated in an independent patient cohort [100]. This evidence concerns the gene DLX1 and posterior cortical atrophy.